Prognia
Drug Database
🇪🇺EU · EMAAuthorisedATC: R06AX27

Desloratadine Actavis(desloratadine)

Rhinitis, Allergic, Perennial;Urticaria;Rhinitis, Allergic, Seasonal

Marketing Authorisation Holder: Actavis Group PTC ehf

EMA Authorisation: 13/01/2012

INN: desloratadine

Indication

Treatment of allergic rhinitis and urticaria.

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Desloratadine Actavis — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.